Phimume® Percutaneous Left Ventricular Assist System Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 250 participants.

Also called NCT06639321

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose supportive care
Phase
Not applicable
Enrolled
  • 250 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06639321
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06639321. Randomized; no masking; primary purpose supportive care. Start 2024-10-14 (anticipated); primary completion 2025-11-14 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Phimume® Percutaneous Left Ventricular Assist System Study
Intervention (Device)
Percutaneous Ventricular Assist System
Intervention (Device)
extracorporeal membrane oxygenation (ECMO)
Lead sponsor
Shanghai NewMed Medical Co., Ltd. (class: industry)
Collaborator
Shanghai Phigine Medical Technology Co., Ltd. (class: not stated)

Record details

Record id
cardio:ct-nct06639321
Content hash
69c479fec986d049d69dc77666f6ca4e565c4348ec29bc92af677d1ed5516257